Article
Single-cell analysis revealing the metabolic landscape of prostate cancer
23 Apr 2024
Abstract excerpt
ABSTRACT: Tumor metabolic reprogramming is a hallmark of cancer development, and targeting metabolic vulnerabilities has been proven to be an effective approach for castration-resistant prostate cancer (CRPC) treatment. Nevertheless, treatment failure inevitably occurs, largely due to cellular heterogeneity, which cannot be deciphered by traditional bulk sequencing techniques. By employing computational pipelines...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
